1. Home
  2. ZVRA vs DOMO Comparison

ZVRA vs DOMO Comparison

Compare ZVRA & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • DOMO
  • Stock Information
  • Founded
  • ZVRA 2006
  • DOMO 2010
  • Country
  • ZVRA United States
  • DOMO United States
  • Employees
  • ZVRA N/A
  • DOMO N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • DOMO Computer Software: Prepackaged Software
  • Sector
  • ZVRA Health Care
  • DOMO Technology
  • Exchange
  • ZVRA Nasdaq
  • DOMO Nasdaq
  • Market Cap
  • ZVRA 400.8M
  • DOMO 324.2M
  • IPO Year
  • ZVRA 2015
  • DOMO 2018
  • Fundamental
  • Price
  • ZVRA $8.01
  • DOMO $8.27
  • Analyst Decision
  • ZVRA Strong Buy
  • DOMO Hold
  • Analyst Count
  • ZVRA 8
  • DOMO 6
  • Target Price
  • ZVRA $22.29
  • DOMO $10.25
  • AVG Volume (30 Days)
  • ZVRA 454.0K
  • DOMO 298.7K
  • Earning Date
  • ZVRA 05-13-2025
  • DOMO 05-22-2025
  • Dividend Yield
  • ZVRA N/A
  • DOMO N/A
  • EPS Growth
  • ZVRA N/A
  • DOMO N/A
  • EPS
  • ZVRA N/A
  • DOMO N/A
  • Revenue
  • ZVRA $23,612,000.00
  • DOMO $317,044,000.00
  • Revenue This Year
  • ZVRA $267.44
  • DOMO $0.86
  • Revenue Next Year
  • ZVRA $90.10
  • DOMO $1.58
  • P/E Ratio
  • ZVRA N/A
  • DOMO N/A
  • Revenue Growth
  • ZVRA N/A
  • DOMO N/A
  • 52 Week Low
  • ZVRA $4.20
  • DOMO $6.01
  • 52 Week High
  • ZVRA $9.76
  • DOMO $10.15
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 60.10
  • DOMO 60.68
  • Support Level
  • ZVRA $7.26
  • DOMO $7.41
  • Resistance Level
  • ZVRA $8.10
  • DOMO $7.97
  • Average True Range (ATR)
  • ZVRA 0.36
  • DOMO 0.33
  • MACD
  • ZVRA 0.09
  • DOMO 0.13
  • Stochastic Oscillator
  • ZVRA 91.45
  • DOMO 97.22

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: